Publication | Closed Access

A Prospective, Double-Blind, Multicenter, Randomized Trial Comparing Ertapenem 3 Vs ≥5 Days in Community-Acquired Intraabdominal Infection

AntibioticsHealthcare-associated InfectionOutcomes ResearchCommunity-acquired Intraabdominal InfectionInfection ControlClinical Infectious DiseaseMedicineClinical MicrobiologyEpidemiologyVs ≥5 Days